93 phenotypes from 9 alleles in 9 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Cdkn1btm1Ako/Cdkn1btm1Ako involves: 129S1/Sv	abnormal prostate gland dorsolateral lobe morphology	J:115443
	abnormal prostate gland physiology	J:115443
	abnormal response/metabolism to endogenous compounds	J:115443
	abnormal tooth morphology	J:102001
	decreased circulating testosterone level	J:115443
	increased body weight	J:118516
	increased brain weight	J:118516
	increased brown adipose tissue amount	J:118516
	increased circulating cholesterol level	J:118516
	increased inguinal fat pad weight	J:118516
	increased kidney weight	J:118516
	increased lung adenocarcinoma incidence	J:120835
	increased ovary tumor incidence	J:236161
	increased parametrial fat pad weight	J:118516
	increased white fat cell number	J:118516
Cdkn1btm1Ako/Cdkn1btm1Ako involves: 129S1/Sv * C57BL	abnormal fetal cardiomyocyte proliferation	J:57380
	decreased myocardial fiber size	J:57380
	enlarged heart	J:57380
	heart hyperplasia	J:57380
	increased heart weight	J:57380
	increased myocardial fiber number	J:57380
Cdkn1btm1Ako/Cdkn1btm1Ako involves: 129S1/Sv * C57BL/6	abnormal corpus luteum morphology	J:33401
	abnormal pituitary intermediate lobe morphology	J:50053
	female infertility	J:33401
	increased body weight	J:33401
	increased pituitary gland tumor incidence	J:50053
	increased spleen weight	J:33401
	increased thymocyte number	J:33401
	increased thymus weight	J:33401
	pituitary intermediate lobe hyperplasia	J:33401, J:50053
	prolonged estrous cycle	J:33401
	prolonged estrus	J:33401
Cdkn1btm1Jro/Cdkn1btm1Jro involves: 129S4/SvJaeSor * C57BL/6	decreased cell proliferation	J:71780
	decreased keratinocyte proliferation	J:71780
	decreased T cell proliferation	J:71780
	delayed wound healing	J:71780
	increased body weight	J:71780
Cdkn1btm1Kin/Cdkn1btm1Kin involves: 129P2/OlaHsd * C57BL/6	abnormal eye electrophysiology	J:33402
	abnormal granulosa cell morphology	J:33402
	abnormal Muller cell morphology	J:33402
	abnormal ovarian follicle morphology	J:33402
	abnormal pituitary intermediate lobe morphology	J:33402
	abnormal retina outer limiting membrane morphology	J:33402
	abnormal retina photoreceptor morphology	J:33402
	abnormal retina pigment epithelium morphology	J:33402
	abnormal uterus morphology	J:33402
	absent corpus luteum	J:33402
	absent tertiary ovarian follicles	J:33402
	adrenal medulla hyperplasia	J:33402
	disorganized retina layers	J:33402
	endometrium hyperplasia	J:33402
	enlarged adrenal glands	J:33402
	enlarged ovary	J:33402
	enlarged prostate gland	J:33402
	enlarged spleen	J:33402
	enlarged testis	J:33402
	enlarged thymus	J:33402
	female infertility	J:33402
	impaired ovarian folliculogenesis	J:33402
	increased amacrine cell number	J:33402
	increased body size	J:33402
	increased body weight	J:33402
	increased pituitary adenoma incidence	J:33402
	increased pituitary gland weight	J:33402
	increased T cell number	J:33402
	pituitary intermediate lobe hyperplasia	J:33402
	testicular hyperplasia	J:33402
	thymus hyperplasia	J:33402
Cdkn1btm1Mlf/Cdkn1b+ involves: 129S4/SvJaeSor	increased incidence of tumors by chemical induction	J:103819
Cdkn1btm1Mlf/Cdkn1b+ involves: 129S4/SvJaeSor * C57BL/6NHsd	increased cochlear inner hair cell number	J:53290
Cdkn1btm1Mlf/Cdkn1btm1Mlf involves: 129S4/SvJaeSor	abnormal neuron differentiation	J:109091
	abnormal neuronal migration	J:109091
	enlarged spleen	J:107588
	enlarged thymus	J:107588
	increased incidence of tumors by chemical induction	J:103819
	spleen hypoplasia	J:107588
Cdkn1btm1Mlf/Cdkn1btm1Mlf involves: 129S4/SvJaeSor * C57BL/6J	abnormal cerebral cortex morphology	J:33400
	abnormal definitive hematopoiesis	J:33400
	abnormal epithalamus morphology	J:33400
	abnormal hepatocyte morphology	J:33400
	abnormal hippocampus morphology	J:33400
	abnormal retina neuronal layer morphology	J:33400
	abnormal spleen morphology	J:33400
	abnormal thymus morphology	J:33400
	absent corpus luteum	J:33400
	disorganized retina layers	J:33400
	enlarged pituitary gland	J:33400
	enlarged spleen	J:33400
	enlarged thymus	J:33400
	female infertility	J:33400
	increased body weight	J:33400
	increased pituitary adenoma incidence	J:33400
	increased T cell proliferation	J:33400
	pituitary gland hyperplasia	J:33400
	premature death	J:33400
	spleen hyperplasia	J:33400
	thymus hyperplasia	J:33400
Cdkn1btm1Mlf/Cdkn1btm1Mlf involves: 129S4/SvJaeSor * C57BL/6NHsd	abnormal cell proliferation	J:53290
	abnormal organ of Corti morphology	J:53290
	abnormal pillar cell morphology	J:53290
	normal behavior/neurological phenotype	J:53290
	impaired hearing	J:53290
	increased body size	J:53290
	increased cochlear hair cell number	J:53290
	increased cochlear inner hair cell number	J:53290
	increased cochlear outer hair cell number	J:53290
	increased or absent threshold for auditory brainstem response	J:53290
	increased organ of Corti supporting cell number	J:53290
Cdkn1btm2.1Mlf/Cdkn1btm2.1Mlf involves: 129S4/SvJaeSor	premature death	J:107588
Cdkn1btm2Jro/Cdkn1btm2Jro involves: 129S4/SvJaeSor * C57BL/6	decreased incidence of tumors by chemical induction	J:103819
Cdkn1btm2Mlf/Cdkn1btm2Mlf Tg(Pomc1-cre)1Mlf/0 involves: 129S4/SvJaeSor	increased pituitary gland tumor incidence	J:107588
	premature death	J:107588
Cdkn1btm3Mlf/Cdkn1btm3Mlf involves: 129S4/SvJaeSor	increased body size	J:107588
	increased pituitary gland tumor incidence	J:107588
	premature death	J:107588
Cdkn1btm3Mlf/Cdkn1btm3Mlf Tg(Pomc1-cre)1Mlf/0 involves: 129S4/SvJaeSor	decreased tumor incidence	J:107588
	premature death	J:107588
Gt(ROSA)26Sortm1(Cdkn1b,EGFP)Dor/Gt(ROSA)26Sor+ Myl2tm1(cre)Krc/Myl2+ involves: 129/Sv * 129S4/SvJae * C57BL/6	heart hypoplasia	J:131577
	thin ventricular wall	J:131577
Gt(ROSA)26Sortm1(Cdkn1b,EGFP)Dor/Gt(ROSA)26Sortm1(Cdkn1b,EGFP)Dor Myl2tm1(cre)Krc/Myl2+ involves: 129/Sv * 129S4/SvJae * C57BL/6	heart hypoplasia	J:131577
	thin ventricular wall	J:131577